Tentative FDA Approval for Generic Version of Taxol

Article

(MIAMI, FL)Ivax, Corporation has received tentative approval from the Food and Drug Administration (FDA) for paclitaxel, a generic form of the cancer drug Taxol, made by Bristol-Myers Squibb Company. However, due to a pending lawsuit and patent litigation against Bristol-Myers, it may be as long as 30 months until Ivax can begin selling the new drug. If Ivax obtains final clearance to sell the generic form of Taxol, it is entitled to 180 days of marketing exclusivity for having been the first to file with the FDA. For more information, visit www.fda.org.

Related Videos
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Related Content